A sponsor needed to enroll at least 200 patients for a pivotal Phase IIIb clinical trial — right when the U.S. issued COVID-19 stay-at-home orders.
Frenova leveraged its clinical research site network and project management expertise to help them exceed their target, activating all sites within three months.
How did we do it?
